Cancer Care Ontario | Cancer Care Ontario

249 Results

Document

[PDF]

Antiemetics for Treatment of Chemotherapy-Induced Nausea and Vomiting (CINV)

Guidelines and Advice

Alemtuzumab for the Treatment of T-cell Prolymphocytic Leukemia

Status: Archived
ID: 6-22

Jan 2007

Acute Lymphoblastic Leukemia: What to Expect During Intensive Chemotherapy Treatment

This page is for people newly diagnosed with ALL.

Guidelines and Advice

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Status: Archived
ID: 6-23 (CED)

Jan 2012

Guidelines and Advice

Dose Objectives for Head and Neck IMRT Treatment Planning - Recommendation Report

Status: Current
ID: GL-C50-13

Feb 2014

Guidelines and Advice

Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women with Early Stage Invasive Breast Cancer

Status: Archived
ID: 1-9

Jun 2010

Guidelines and Advice

A Pan-Canadian Practice Guideline: Prevention, Screening, Assessment and Treatment of Sleep Disturbances in Adults with Cancer

Status: Education and Information

Dec 2012

Guidelines and Advice

Doxorubicin-Based Chemotherapy for the Palliative Treatment of Adult Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Status: Archived
ID: 11-1
Version: 2

Oct 2014

Guidelines and Advice

An Endorsement of the ASTRO/ESTRO 2023 Guideline for the Treatment of Patients with Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

Status: Current
ID: GL END 7-24

Nov 2024

Guidelines and Advice

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Status: Current
ID: GL END 5-7
Version: 3

Nov 2021

Guidelines and Advice

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Status: Current
ID: GL-END-C50-35

Aug 2023

Antiemetics for Treatment of Chemotherapy-Induced Nausea and Vomiting (CINV)

Alemtuzumab for the Treatment of T-cell Prolymphocytic Leukemia

Acute Lymphoblastic Leukemia: What to Expect During Intensive Chemotherapy Treatment

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Dose Objectives for Head and Neck IMRT Treatment Planning - Recommendation Report

Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women with Early Stage Invasive Breast Cancer

A Pan-Canadian Practice Guideline: Prevention, Screening, Assessment and Treatment of Sleep Disturbances in Adults with Cancer

Doxorubicin-Based Chemotherapy for the Palliative Treatment of Adult Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

An Endorsement of the ASTRO/ESTRO 2023 Guideline for the Treatment of Patients with Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

About Radiation

Pages